Dataset Information


Synthesis, Characterization, and In Vitro Cancer Cell Growth Inhibition Evaluation of Novel Phosphatidylcholines with Anisic and Veratric Acids.

ABSTRACT: Phenolic acids and its methoxy derivatives are known to induce caspase-mediated apoptosis activity and exhibit cytotoxic effect towards various cancer cell lines. However, their low stability and poor bioavailability in the human organism extensively restrict the utility of this group of compounds as anticancer and health-promoting agents. In this report, a series of eight novel phosphatidylcholines (3a-b, 5a-b, 7a-b, 8a-b) containing anisic or veratric acids (1a-b) at sn-1 and/or sn-2 positions were synthesized. The phenoylated phospholipids were obtained in good yields 28?66%. The structures of novel compounds were determined by their spectroscopic data. All synthesized compounds were evaluated for their antiproliferative activity towards six cancer cell lines and normal cell line Balb/3T3. Lipophilization of phenolcarboxylic acids significantly increased their anticancer properties. The asymmetrically substituted phenoylated phosphatidylcholines exhibited higher antiproliferative effect than free acids. Lysophosphatidylcholine (7b) effectively inhibited the proliferation of human leukaemia (MV4-11), breast (MCF-7), and colon (LoVo) cancer cell lines at concentrations of 9.5?20.7 µm and was from 19 to 38-fold more active than corresponding free veratric acid. The conjugation of anisic/veratric acids with the phosphatidylcholine have proved the anticancer potential of these phenolcarboxylic acids and showed that this type of lipophilization is an effective method for the production of active biomolecules.

SUBMITTER: Czarnecka M 

PROVIDER: S-EPMC6222722 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC4911001 | BioStudies
2017-01-01 | S-EPMC5308787 | BioStudies
1000-01-01 | S-EPMC6338774 | BioStudies
2020-01-01 | S-EPMC7230207 | BioStudies
2018-01-01 | S-EPMC6017559 | BioStudies
1000-01-01 | S-EPMC4950057 | BioStudies
1000-01-01 | S-EPMC4949577 | BioStudies
2007-01-01 | S-EPMC2915541 | BioStudies
2014-01-01 | S-EPMC3895536 | BioStudies
1984-01-01 | S-EPMC1144507 | BioStudies